ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

Rewritten Five Year Plan For Centers Is Greeted Warmly By NCAB Committee

April 27, 1990

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977